Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
An update from MEDIROM Healthcare Technologies ( (MRM) ) is now available.
MEDIROM Healthcare Technologies Inc. announced that two senior executives of its subsidiary, MEDIROM MOTHER Labs, invested in the company’s Series A financing, reflecting their commitment to the company’s growth and vision. This investment at a valuation of JPY9 billion (USD $59,000,000) underscores the confidence in MEDIROM’s innovative health-tech solutions, particularly its MOTHER Bracelet, which enhances health management capabilities for diverse sectors, potentially strengthening its market position and stakeholder value.
More about MEDIROM Healthcare Technologies
MEDIROM Healthcare Technologies Inc. operates in the health-tech sector, focusing on providing innovative health management solutions. Its subsidiary, MEDIROM MOTHER Labs Inc., offers services such as the Specific Health Guidance Program through the Lav health application and develops the recharge-free MOTHER Bracelet smart tracker. These offerings allow for customizable health management across various industries, including caregiving, logistics, and manufacturing.
YTD Price Performance: -71.33%
Average Trading Volume: 145,422
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.1M
For an in-depth examination of MRM stock, go to TipRanks’ Stock Analysis page.
